PaHa09g16800

Functional evidence

eggNOG

Preferred name: LOC103706673 | Seed ortholog: 337451.A0A3S4NGM2 | COG: S | eggNOG OG: Myb_DNA-binding@131567|KR-16, Myb_DNA-binding@2759|ja-21

Gene Ontology

GO:0000118 histone deacetylase complex; GO:0000122 negative regulation of transcription by RNA polymerase II; GO:0000785 chromatin; GO:0000976 transcription cis-regulatory region binding; GO:0000977 RNA polymerase II transcription regulatory region sequence-specific DNA binding; GO:0001701 in utero embryonic development; GO:0002155 regulation of thyroid hormone receptor signaling pathway; GO:0002361 CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation; GO:0003007 heart morphogenesis; GO:0003677 DNA binding; GO:0003682 chromatin binding; GO:0003714 transcription corepressor activity; GO:0005112 Notch binding; GO:0005515 protein binding; GO:0005634 nucleus; GO:0005654 nucleoplasm; GO:0005667 transcription regulator complex; GO:0005737 cytoplasm; GO:0005829 cytosol; GO:0006357 regulation of transcription by RNA polymerase II; GO:0008047 enzyme activator activity; GO:0008284 positive regulation of cell population proliferation; GO:0008544 epidermis development; GO:0009952 anterior/posterior pattern specification; GO:0010467 gene expression; GO:0010565 regulation of ketone metabolic process; GO:0010629 negative regulation of gene expression; GO:0016020 membrane; GO:0016363 nuclear matrix; GO:0016604 nuclear body; GO:0016922 nuclear receptor binding; GO:0017053 transcription repressor complex; GO:0019904 protein domain specific binding; GO:0021537 telencephalon development; GO:0021794 thalamus development; GO:0021846 cell proliferation in forebrain; GO:0030097 hemopoiesis; GO:0030099 myeloid cell differentiation; GO:0030223 neutrophil differentiation; GO:0030225 macrophage differentiation; GO:0030331 nuclear estrogen receptor binding; GO:0030900 forebrain development; GO:0030902 hindbrain development; GO:0032922 circadian regulation of gene expression; GO:0035033 histone deacetylase regulator activity; GO:0035259 nuclear glucocorticoid receptor binding; GO:0040014 regulation of multicellular organism growth; GO:0042593 glucose homeostasis; GO:0042632 cholesterol homeostasis; GO:0042826 histone deacetylase binding; GO:0042974 nuclear retinoic acid receptor binding; GO:0042975 peroxisome proliferator activated receptor binding; GO:0043565 sequence-specific DNA binding; GO:0044877 protein-containing complex binding; GO:0045475 locomotor rhythm; GO:0045599 negative regulation of fat cell differentiation; GO:0045820 negative regulation of glycolytic process; GO:0045892 negative regulation of DNA-templated transcription; GO:0045922 negative regulation of fatty acid metabolic process; GO:0046329 negative regulation of JNK cascade; GO:0046965 nuclear retinoid X receptor binding; GO:0046966 nuclear thyroid hormone receptor binding; GO:0048471 perinuclear region of cytoplasm; GO:0050821 protein stabilization; GO:0050872 white fat cell differentiation; GO:0051225 spindle assembly; GO:0051898 negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; GO:0060218 hematopoietic stem cell differentiation; GO:0060318 definitive erythrocyte differentiation; GO:0060509 type I pneumocyte differentiation; GO:0060633 negative regulation of transcription initiation by RNA polymerase II; GO:0060766 negative regulation of androgen receptor signaling pathway; GO:0060816 random inactivation of X chromosome; GO:0061436 establishment of skin barrier; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding; GO:0072686 mitotic spindle; GO:0090312 positive regulation of protein deacetylation; GO:1902894 negative regulation of miRNA transcription; GO:1904017 cellular response to Thyroglobulin triiodothyronine; GO:1990837 sequence-specific double-stranded DNA binding

KEGG

KO: K04650, K06065 | Pathway: 01522, 04330, 04350, 04919, 05169, 05202 | BRITE: 00001, 01009, 03036